Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.

Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However,...

Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.

Revvity's (RVTY) strong product portfolio raises optimism about the stock.

Welltower (WELL) is likely to benefit from the rise in senior citizens' healthcare spending, restructuring initiatives and capital-recycling efforts....

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

Fiserv (FI) benefits from its business model, client addition and retention, and providing value-added solutions to its clients.

Fiserv (FI) benefits from its business model, client addition and retention, and providing value-added solutions to its clients.